Several diseases have clinical signs of neurologic dysfunction. However, in cases of equine herpesvirus-1 myeloencephalopathy (the neurologic form), these neurologic signs reflect diffuse multifocal hemorrhagic vasculitis and thrombosis, meaning the virus has damaged the lining of the blood vessels in the central nervous system, leading to inflammation and clots.
Pam Wilkins, DVM, MS, PhD, Dipl. ACVIM, ACVECC, of the University of Pennsylvania's New Bolton Center, discussed several poorly understood aspects of equine herpesvirus-1 infection (such as latency, vaccination, treatment, and outbreak control) at a 2007 meeting hosted by the C.L. Davis Foundation and the American Association of Veterinary Laboratory Diagnosticians on Equine Herpesviral Diseases.
- Veterinarians Urge Vaccination against West Nile Virus
- Increased Equine West Nile Virus Activity in 2012
- Horse Vaccines in 2012: Where We Stand
- EHV-1 Inactivated Vaccine Efficacy Tested (AAEP 2011)
- Biosecurity for Hospitals and Horse Farms
- Neurologic EHV-1: An Overview
- Management Strategies to Enhance Vaccine Efficacy
- Diagnosing Neurologic EHV-1: Back to Basics
- EHV-1 Outbreak: Case Total Holding Steady
- EHV-1 Outbreak: Additional Cases Reported Over Weekend